Abstract
Heart valve prostheses have been used successfully since 1960. As stated by Roberts [1] the 1960s will probably be remembered most in the annals of cardiology as the decade during which cardiac valve replacement became a successful reality. Of the more than 50 different cardiac valves introduced over the past 25 years, many have been discarded due to their lack of success, and of those remaining several modifications have been made or are being made at the time of this writing. The five most commonly used basic types of prosthetic valves at present are: caged ball, caged disc, tilting disc, bi-leaflet and bio-prostheses. At present over 75 000 prosthetic valves of different designs are used annually throughout the world. Even after 25 years of experience the problems associated with heart valve prostheses have not been totally eliminated. The most serious problems and complications associated with heart valve prostheses are: thromboembolism, tissue overgrowth, infection, tearing of sewing sutures, red cell destruction (haemolysis), valve failure due to material fatigue or chemical change, damage to the endothelial tissue lining of the vessel wall adjacent to the valve and leaks caused by failure of the valve to close properly. Thromboembolism, tissue overgrowth, red cell destruction and endothelial damage are directly related to the fluid dynamics associated with the various prosthetic heart valves and need to be addressed in more detail by investigators studying biofluid mechanics. The other problems are indirectly related to fluid mechanics. Problems relating to valve failure due to material fatigue or chemical change also need to be studied, especially in relation to bioprostheses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Roberts WC. Am J Cardiol 1976; 38:633
Starr A. Surg Forum 1960; 11: 258–260
Cartwright RS, Palick WE, Ford WB, Giacobine JW, Zubritsky SA, Ratan RS. JAMA 1962; 180: 6–12
Ross DN. Lancet 1962;ii:487
Wain EH, Greco R, Ignegeri A, Bodnar E, Ross DN. Int J Artif Organs 1980; 3: 169–172
Ross DN. Lancet 1967; ii:956
Senning A. Acta Chir Scand [Suppl] 1966; 356B: 17–20
lonescu MI, Ross DN. Lancet 1969; ii:335–338
Senning A. Thoraxchirurgie, 1971; 19: 304–308
Kaiser GA, Hancock WD, Lukban SB, Litwak RS. Surg Forum 1969; 20: 137–138
Reis RL, Hancock WD, Yarborough JW, Glancy DL, Morrow AG. J Thorac Cardiovasc Surg 1971; 62: 683–689
Ionescu MI, Mary DAS, Abid A. In: Stalpaert G et al. (eds) Late results of valvular replacements and coronary surgery. European Press, Ghent, p 56
Ferrans VJ, Spray TL, Billingham ME, Roberts WC. Am J Cardiol 1978; 41: 1159
Ferrans VJ, Boyce SW, Billingham ME, Jones M, Ishihara R, Roberts WC. Am J Cardiol 1980; 46: 721
Oyer PE, Stinson EB, Reitz BA, Miller DC, Rossiter SJ, Shumway NE. J Thorac Cardiovasc Surg 1979; 78: 343
Yoganathan AP. Prosthetic heart valves: a study of in vitro performance. Phase I final report, FDA Contract no. 223-81-5000, April 1982 (NTI S no. PB 83-134478)
Reece IJ, Van Noort R, Martin TRP, Black MM. Ann Thorac Surg 1982; 33: 480–485
Black MM, Drury PJ, Tindale WB. Proceedings of the European Society for Artificial Organs 1982; 9: 116–119
Ghista DN, Reul H. J Biomech 1977; 10 (56): 313
Reul H. In: Planck H et al. (eds) Polyurethanes in biomedical engineering. Elsevier Science Publishers, Amsterdam, 1984, pp 257–277
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag London Limited
About this chapter
Cite this chapter
Yoganathan, A.P., Reul, H., Black, M.M. (1992). Heart Valve Replacements: Problems and Developments. In: Hastings, G.W. (eds) Cardiovascular Biomaterials. Springer, London. https://doi.org/10.1007/978-1-4471-1847-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1847-3_5
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1849-7
Online ISBN: 978-1-4471-1847-3
eBook Packages: Springer Book Archive